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Autoimmune diseases such as systemic lupus erythematosus are characterized
by antibodies reactive with a wide variety of autoantigens including DNA, cell
surface molecules, and intracellular matrix proteins (1, 2) . Some investigators
attribute the diversity of autoantibodies in these diseases to generalized (polyclo-
nal) activation of Ig-producing B cells (1, 3) . Others believe that autoreactive
clones are specifically and preferentially stimulated but that B cells producing
antibodies of conventional specificity remain quiescent (4). This second view is
supported by several findings : (a) autoreactive clones proliferate preferentially
in organ-specific autoimmune diseases (5), (b) there is evidence that autoreactive
B cells arise from a physiologically distinct subpopulation of Ly-l + lymphocytes,
which may be abnormally responsive to immune stimulatory signals (6), (c) B
cells capable of autoantibody production expand more rapidly than other lym-
phocytes when transferred into B cell-depleted recipients (7), and (d) adult
autoimmune mice respond poorly (or notat all) to immunization with exogenous
antigens (8) .
The analysis of systemic autoimmunity has been facilitated by the availability
of animal models of human SLE, such as mice that spontaneously develop
hypergammaglobulinemia and elevated levels of serum autoantibodies (1, 9) . In
this report, Ig secreting cells and serum from autoimmune and congenic non-
autoimmune mice were studied for reactivity with a panel of seven autoantigens
and two conventional antigens . Our results suggest that systemic autoimmunity
results from generalized polyclonal activation and not from specific stimulation
of autoreactive clones .
Materials and Methods
Animals . NZB, BXSB, and congenic xid mice were bred and raised in our animal
colony. MRL and DBA/2 mice were purchased from The Jackson Laboratory (Bar
Harbor, ME). All mice used in these experiments were 4-8-mo-old females unless
otherwise stated .
ELISA .
￿
Flat-bottomed Immunlon I microtiter plates (Dynatech Labs, Alexandria, VA)
were coated with soluble protein (10) or glutaraldehyde-fixed cell surface antigens (11)
and then blocked with 1% BSA in PBS as previously described (7) . Dilutions of sera
derived from blood clotted at 37°C for 90 min were incubated on antigen-coupled plates
for 2 h . Unbound Ig was washed away with PBS/0.05%Tween 20 . Alkaline phosphatase-
conjugated anti-mouse Ig (Kirkegaard and Perry Laboratories, Inc., Gaithersburg, MD)
was added for 2 h, and the plates were again washed . The concentration of specific
antibodybound to theplate was determined by comparison to a standard curve generated
using known dilutions of high-titered antisera, as previously described (7) .
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FIGURE 1 .
￿
The amount of antigen-specific antibody in the sera of seven mice from each
strain was measured by ELISA . The relative increase in antibody titer of autoimmune mice
relative to their congenic non-autoimmune counterparts was assessed by comparison to serially
diluted standard antisera, as previously described (7) . Antibodies against conventional antigens
(narrow crosshatched bars) and against autoantigens (wide crosshatched bars) contributed equally
to the increase in total IgM and IgG levels in autoimmune mice .
Spot ELISA .
￿
Single-cell suspensions were made from the spleens of freshly killed mice
in medium consisting ofRPMI 1640 supplemented with 2% FSC . Serial dilutions ofthese
suspensions, starting with 106 cells/well, were incubated on antigen-coated plates for 7 h
at 37°C in a 5% C02 in air incubator . The cells were washed away with PBS/0 .05%
Tween 20 and the plates overlaid with phosphatase-conjugated anti-mouse Ig for 2 h
(12) . Antibodies, produced by individual B cells, that bound to the plate were visualized
by addition of a 5-bromo-3-chloroindolyl phosphate solution (Sigma Chemical Co ., St .
Louis, MO) in a low-melt agarose kept at 44°C . Phosphatase acts on this substrate to
produce a blue spot that cannot diffuse through the agarose once it solidifies at room
temperature (12) .
Results and Discussion
Serum Antibody Levels in Autoimmune Mice Reflect Polyclonal Activation .
￿
Sera
from mice of three autoimmune strains : NZB, MRL lpr/lpr, and BXSB were
analyzed for antibodies reactive with a panel of six autoantigens and two conven-
tional antigens, and for total IgM and IgG content . Sera from congenic counter-
parts of each strain that had not developed autoimmune disease were used as
standards to determine whether autoimmune mice produced antibodies prefer-
entially against one or more of these antigens (1, 9) . We found that comparable
increases in the concentration of antibodies reactive with both self antigens and
conventional antigens contributed to the hypergammaglobulinemia of autoim-
mune mice (Fig . 1) .
Ig-secreting Cellsfrom Autoimmune Mice Reflect Polyclonal Activation .
￿
It is diffi-
cult to accurately determine the rate of synthesis of individual antibody specific-
ities compared to the total Ig pool (13) .A precise way of analyzing Ig productionKLINMAN AND STEINBERG
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FIGURE 2 .
￿
NZB and MRL lpr/lpr spleen cells were incubated on antigen coated plates in the
presence of various concentrations of competing antigen. Only when the competing antigen
was identical to the antigen coupled to the plate was there significant inhibition of ELISA spot
formation by cells from either strain .
1757
is to identify and count individual B cells secreting antibodies against known
antigens . This can be accomplished usinga spot ELISA, in which freshly isolated
splenic lymphocytes are cultured in plastic dishes to which specific antigens are
adsorbed . Only antibodies binding to the adsorbed antigen remain on the dish
when it is washed free of B cells and nonspecific Ig . These antigen-bound
antibodies mark the position of the B cells that produced them and can be
detected as discrete blue spots in a colorimetric spot-developing assay (12) .
The sensitivity and specificity of this assay have been documented (11, 12, 14)
and confirmed for the antigens studied in this report in several ways: (a) ELISA
spots were competitively inhibited by the addition of homologous but not
heterologous antigen (Fig . 2), (b) hybridoma cells producing antibodies ofknown
specificity could be individually counted on plates coated with their target
antigen, but not other antigens, (data not shown), and (c) antigenic stimulation
in vivo led to a specific increase in the frequency ofB cells producing antibodies
of the corresponding specificity but not of other specificities (data not shown) .
The absolute number of Ig-secreting B cells and the number of B cells
producing antibodies reactive with seven autoantigens and two conventional
antigens were independently quantitated in 10 mice from each strain . The
frequency of B cells reactive with many of these antigens had not previously
been described . However, estimates from other laboratories of the total number
of Ig-secreting lymphocytes and the frequency ofanti-DNA and anti-bromelain-
treated mouse red blood cell (BrMRBC)-producing B cells were consistent with
our own (14) . Such estimates, derived using the spot ELISA, were generally
several fold higher than those described when less sensitive hemolytic plaque
assays were used (15) .
As has been described previously, the absolute number of anti-DNA-secreting
B cells was significantly greater in spleens from autoimmune as opposed to1758
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FIGURE 3 .
￿
Splenic lymphocytes from 5-mo-old female MRL lpr/lpr (crosshatched bars) and
MRL +/+ (solid bars) mice were analyzed by the ELISA spot technique . The absolute number
of Ig secreting B cells and the number producing antibodies against DNA, TNP-KLH, and
myosin is shown for four mice from each strain in the top panel. Note the significant difference
between MRL lpr/lpr (crosshatched bars) and congenic non-autoimmune mice (solid bars) in
terms of the absolute number of antibody-producing B cells . The number of lymphocytes
producing antibodies of each specificity was divided by the total number of Ig secreting
lymphocytes from that animal (bottom panels) . Note the now-identifiable similarity in the
repertoires of these congenic strains of mice .
congenic non-autoimmune mice (Fig . 3, top) . So too were the number of anti-
myosin, anti-TNP-KLH (a conventional antigen)and total Ig-secreting cells (Fig .
3, top) . Whereas other investigators have reported that autoantibody-secreting B
cells are quantitatively increased in autoimmune mice, they could not determine
whether polyclonal activation or specific stimulation caused the expansion of
autoreactive lymphocytes (1, 9, 15, 16) . By simultaneously quantitating both
antigen-specific and total Ig-secreting B cells, we could calculate the frequency
of antigen-specific lymphocytes as a percentage o£ the total expressed repertoire
in each animal . Analyzing the data in this manner permitted thenovel observation
that autoimmune and congenic non-autoimmune mice devoted a very similar
proportion of their B cell repertoires to the production ofanti-DNA antibodies
(Fig . 3, bottom) .
A compilation of the data from all mice tested supported this conclusion : the
proportion of B cells producing antibodies of each antigenic specificity, as a
percentage of the total expressed repertoire, was virtually identical among
autoimmune and congenic non-autoimmune mice (Table I) . Furthermore, B
cells producing antibodies against conventional antigens increased ata frequency
commensurate with that of autoantibody-secreting lymphocytes. For example,
anti-DNA-producing B cells (considered the sine qua non of autoimmunity in
NZB mice)were present with equal frequency in the repertoires ofNZB, NZB.xid
and normal DBA/2 mice . Moreover, the relative number of B cells secreting
antibodies against conventional antigens increased in NZB mice to the same
extent as those producing anti-DNA .KLINMAN AND STEINBERG
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TABLE I
Spontaneous Antibody Production by Various Strains
Summary
The frequency of B cells producing antibodies reactive with each antigen, expressed as a percentage of the total number
of Ig secreting cells, is shown (± SE) . 10 mice of each strain were studied individually by ELISA spot assay . NZBmice had
an average of 23,162 Ig-secretingB cells per 10 6 splenic lymphocytes, in comparison to NZB.xid mice with only 670 per
10 6 (the xid gene interferes with the maturation of B cells, and subsequent antibody production [71) . The lymphoprolifer-
ation (lpr) gene of MRLlpr/lpr mice leads to the early onset of autoimmunity in that strain (19,391 Ig secreting cells per
10 6 cells) when compared to MRL +/+mice (2,168 cells in 106), just as the BXSB Y chromosome-linked autoimmunity-
accelerating gene leads to early disease in BXSB male mice (16,947 in 106) when compared to BXSB females (2,907 in 106
[11) . DBA/2 mice had 902 spontaneously active B cells per 10 6 spleen cells . Note that the proportion of B cells producing
antibodies against both conventional (TNP-KLH and ovalbumin) and autoantigens was virtually identical among congenic
mice .
In a few instances, congenic mice differed in the proportion of their B cell
repertoire devoted to particular antigenic specificities : B cells producing anti-T
cell and antimyosin antibodies were expressed more frequently in male than
female BXSB mice . These rare exceptions indicate that preferential activation
of certain B cell clones may occur in lupus-like autoimmune diseases .
As a general rule, the hypergammaglobulinemia that developed in NZB,
BXSB, and MRL 1pr/1pr mice resulted from a proportionate increase in the
number of B cells producing antibodies to all antigens studied. These results
demonstrate for the first time that systemic au ,oimmunity arises from polyclonal
B cell activation rather than the preferential stimulation ofautoreactive lympho-
cytes. This conclusion is consistent with previous experiments showing that
systemic autoimmune disease could be induced by treating normal mice with
polyclonal activators (16) . We conclude that therapy of patients with systemic
lupus erythematosus might fruitfully be directed towards control of polyclonal
activation rather than at immune responses to self antigens, and that research
into systemic autoimmune diseases be directed towards identifying the source(s)
and nature of those agents responsible for this polyclonal B cell stimulation .
The number of B cells producing antibodies reactive with any of seven
autoantigens or two conventional antigens was compared at the single-cell level
to the total number of Ig-secreting B cells present in the spleens of NZB, MRL
1pr/1pr, andBXSB autoimmune mice . The proportion oflymphocytes producing
antibodies of each specificity, expressed as a percentage of the total B cell
repertoire, was virtually identical among autoimmune and congenic nonautoim-
mune animals . Furthermore, B cells and serum antibodies reactive with conven-
tional antigens increased commensurately with those reactive with autoantigens .
Antibody-secreting B cells producing antibodies reactive with the indicated antigen in strains:
Antigen
NZB NZB.xid MRL lpr/lpr MRL +/+ BXSB male BXSB fe-
male DBA/2
DNA 1.08±0.22 0.76±0.07 1.46±0.16 1 .81 ±0.48 1.19±0.29 0.89±0.30 1.24±0.36
BrMRBC 3.86 ± 1 .49 4.93± 1 .32 4.78±2.17 4.02 ±0.63 4.86 ± 0.96 4.04 ± 1 .44 3.48 ± 0.59
T cell 1.83±0.69 1.86±0.78 0.73±0.11 0.67±0.11 2.30±0.39 0.62±0.12 0.62±0.08
Transferrin 0.03 ± 0.01 0.20± 0.07 0.02±0.01 0.04 ±0.01 0.14 ± 0.02 0.07 ± 0.02 0.02 ± 0.02
Myosin 0.53 ± 0.10 0.54± 0.20 0.23±0.08 0.39 ±0.03 1 .12 ±0.17 0.23 ± 0.07 0.22 ± 0.08
Actin 0.46 ± 0.06 0.53± 0.24 0.21 ±0.10 0.28 ±0.05 0.76 ±0.15 0.24 ± 0.08 0.41 ± 0.05
Thyroglobulin 0.03 ± 0.01 <0.01 0.01 ±0.01 0.01 ±0.01 0.01 ±0.01 0.02 ± 0.01 0.08 ± 0.05
Ovalbumin 0.26 ± 0.03 0.25 ± 0.15 0 .02± 0.01 0.04±0.02 0.19 ±0.05 0.15 ± 0.07 0.06 ± 0.05
TNP-KLH 0.60±0.16 0.69±0.16 0.55±0.15 0.39±0.11 0.54±0.15 0.43±0.10 0.42±0.141760
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These results indicate that systemic autoimmune diseases arise from polyclonal
B cell activation.
We thank Dr. Susan Leitman-Klinman and Dr.Jeffrey Siegel for their constructive review
of this manuscript.
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